These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 36292174)
81. Gingival Inflammation and Salivary or Serum Granulocyte-Secreted Enzymes in Patients With Polycystic Ovary Syndrome. Akcalı A; Bostanci N; Özçaka Ö; Gümüş P; Öztürk-Ceyhan B; Tervahartiala T; Husu H; Buduneli N; Sorsa T; Belibasakis GN J Periodontol; 2017 Nov; 88(11):1145-1152. PubMed ID: 28598286 [TBL] [Abstract][Full Text] [Related]
82. The potential of salivary biomarkers for predicting the sensitivity and monitoring the response to nonsurgical periodontal therapy: A preliminary assessment. Lee CH; Chen YW; Tu YK; Wu YC; Chang PC J Periodontal Res; 2018 Aug; 53(4):545-554. PubMed ID: 29882262 [TBL] [Abstract][Full Text] [Related]
83. Clinical Investigation of Matrix Metalloproteinases, Tissue Inhibitors of Matrix Metalloproteinases, and Matrix Metalloproteinase/Tissue Inhibitors of Matrix Metalloproteinase Complexes and Their Networks in Apical Periodontitis. Martinho FC; Teixeira FF; Cardoso FG; Ferreira NS; Nascimento GG; Carvalho CA; Valera MC J Endod; 2016 Jul; 42(7):1082-8. PubMed ID: 27188765 [TBL] [Abstract][Full Text] [Related]
84. MMP-1, MMP-9, and TIMP-1 levels in oral lichen planus patients with gingivitis or periodontitis. Ertugrul AS; Dursun R; Dundar N; Avunduk MC; Hakki SS Arch Oral Biol; 2013 Jul; 58(7):843-52. PubMed ID: 23433942 [TBL] [Abstract][Full Text] [Related]
85. Bone remodeling biomarkers of periodontal disease in saliva. Frodge BD; Ebersole JL; Kryscio RJ; Thomas MV; Miller CS J Periodontol; 2008 Oct; 79(10):1913-9. PubMed ID: 18834246 [TBL] [Abstract][Full Text] [Related]
86. The effects of selective COX-2 inhibitor/celecoxib and omega-3 fatty acid on matrix metalloproteinases, TIMP-1, and laminin-5gamma2-chain immunolocalization in experimental periodontitis. Vardar-Sengul S; Buduneli E; Turkoglu O; Buduneli N; Atilla G; Wahlgren J; Sorsa T; Baylas H J Periodontol; 2008 Oct; 79(10):1934-41. PubMed ID: 18834249 [TBL] [Abstract][Full Text] [Related]
87. Macrophage activating factor: A potential biomarker of periodontal health status. Zhang P; Fan Y; Li Q; Chen J; Zhou W; Luo Y; Zhang J; Su L; Xue X; Zhou X; Feng Y Arch Oral Biol; 2016 Oct; 70():94-99. PubMed ID: 27341461 [TBL] [Abstract][Full Text] [Related]
88. Importance of MMP-8 in Salivary and Gingival Crevicular Fluids of Periodontitis Patients. Fatemi K; Rezaee SA; Banihashem SA; Keyvanfar S; Eslami M Iran J Immunol; 2020 Sep; 17(3):236-243. PubMed ID: 32996900 [TBL] [Abstract][Full Text] [Related]
89. Changes in salivary matrix metalloproteinase-3, -8, and -9 concentrations after 6 weeks of non-surgical periodontal therapy. Kim HN BMC Oral Health; 2022 May; 22(1):175. PubMed ID: 35562715 [TBL] [Abstract][Full Text] [Related]
90. Diagnostic accuracy of salivary biomarkers of bone turnover in identifying patients with periodontitis in a Saudi Arabian population. Betsy J; Ahmed JM; Mohasin AK; Mohammed A; Nabeeh A A J Dent Sci; 2019 Sep; 14(3):269-276. PubMed ID: 31534637 [TBL] [Abstract][Full Text] [Related]
91. Relationship between salivary leukotriene B4 levels and salivary mucin or alveolar bone resorption, in subjects with periodontal health and disease. Sánchez GA; Miozza VA; Delgado A; Busch L J Periodontal Res; 2013 Dec; 48(6):810-4. PubMed ID: 23488687 [TBL] [Abstract][Full Text] [Related]
92. Effect of smoking on periodontal health. Visvanathan R; Mahendra J; N A; Pandisuba ; Chalini J Clin Diagn Res; 2014 Jul; 8(7):ZC46-9. PubMed ID: 25177637 [TBL] [Abstract][Full Text] [Related]
93. Effect of phase 1 periodontal therapy on gingival crevicular fluid levels of matrix metalloproteinases-3 and -13 in chronic periodontitis patients. Pawar DD; Mehta DS J Investig Clin Dent; 2015 May; 6(2):118-24. PubMed ID: 24357595 [TBL] [Abstract][Full Text] [Related]
95. Correlation of Toll-like receptor 4, interleukin-18, transaminases, and uric acid in patients with chronic periodontitis and healthy adults. Banu S; Jabir NR; Mohan R; Manjunath NC; Kamal MA; Kumar KR; Zaidi SK; Khan MS; Tabrez S J Periodontol; 2015 Mar; 86(3):431-9. PubMed ID: 25345339 [TBL] [Abstract][Full Text] [Related]
96. Tissue inhibitors of metalloproteinases level and collagenase activity in gingival crevicular fluid: the relevance to periodontal diseases. Nomura T; Ishii A; Oishi Y; Kohma H; Hara K Oral Dis; 1998 Dec; 4(4):231-40. PubMed ID: 10200701 [TBL] [Abstract][Full Text] [Related]
97. Impact of non-surgical periodontal therapy on saliva and serum levels of markers of oxidative stress. Önder C; Kurgan Ş; Altıngöz SM; Bağış N; Uyanık M; Serdar MA; Kantarcı A; Günhan M Clin Oral Investig; 2017 Jul; 21(6):1961-1969. PubMed ID: 27807715 [TBL] [Abstract][Full Text] [Related]
98. Validation and verification of predictive salivary biomarkers for oral health. Bostanci N; Mitsakakis K; Afacan B; Bao K; Johannsen B; Baumgartner D; Müller L; Kotolová H; Emingil G; Karpíšek M Sci Rep; 2021 Mar; 11(1):6406. PubMed ID: 33742017 [TBL] [Abstract][Full Text] [Related]
99. Expression of Matrix Metalloproteinases and Tissue Inhibitor of Matrix Metalloproteinases during Apical Periodontitis Development. Wan CY; Li L; Liu LS; Jiang CM; Zhang HZ; Wang JX J Endod; 2021 Jul; 47(7):1118-1125. PubMed ID: 33895237 [TBL] [Abstract][Full Text] [Related]